Boston licenses the BackStop product, a polymer gel plug injected into the ureter via catheter to prevent migration of kidney stone fragments during extraction, from Woburn, Mass.-based Pluromed.
"We are focused on offering minimally invasive and cost-effective medical devices that improve patient outcomes," Boston Scientific executive vice president and MedSurg division president Michael Phalen said in prepared remarks. "The BackStop gel demonstrates this focus by providing a clinically effective method for urologists to manage the common problem of stone migration during treatment procedures."
Sanofi plans to commercialize Pluromed’s LeGoo polymer plug, an injectable gel used during surgical procedures in place of a clamp or snare.
Siemens lands 3rd year defense contract worth up to $1.9 billion
Siemens (NYSE:SI) won a 3rd option year on a contract with the U.S. Defense Dept. to provide radiology systems, subsystems and components to the Army, Navy, Air Force, Marine Corps and federal civilian agencies in a deal with a maximum value of more than $1.9 billion. Read more
Bruker Corp. nabs all shares of SkyScan for an undisclosed amount
Bruker Corp. (NSDQ:BRKR) acquired all shares of scientific instruments maker SkyScan for an undisclosed amount in a deal that’s expected to add approximately $13 million to Bruker’s revenue for the remainder of 2012. Read more
Viking expects 40% sales growth for Q1 2012
Viking Systems (OTC:VKNG) projected 40% sales growth for its 1st quarter of 2012, expecting sales of at least $3.1 million for the 3 months ended March 31 as demand increases for its 3D and 2D visualization systems for complex minimally invasive surgery. Read more
Smith & Nephew acquires LifeModeler for an undisclosed amount
Smith & Nephew (NYSE:SNN) announced the acquisition of LifeModeler Inc., a provider of biomechanical human body simulation tools and services that Smith has worked with for more than a decade. The details of the merger were not made public. Read more
Wound Care Innovations signs exclusive N.A. distribution agreement with Juventas
Wound Care Innovations signed an exclusive North American distribution agreement for its CellerateRX powder product and certain future powder wound care products with Juventas LLC. Read more
BSD Medical renews hyperthermia systems distribution agreement with Dalian Orientech
BSD Medical Corp. (NSDQ:BSDM) renewed its exclusive Chinese distribution agreement with Dalian Orientech for its hyperthermia systems, which use heat therapy to treat cancer. Read more
CaridianBCT and Terumo Transfusion merge
CaridianBCT and Terumo Transfusion announced a merger today, becoming Terumo BCT, a U.S. medical device maker focused on blood banking, transfusion medicine and cellular therapies. Read more
Winner Medical stock soars as chairman & CEO moves to acquire all outstanding shares
Winner Medical Group (NSDQ:WWIN), a manufacturer of medical dressings, medical disposables and non-woven fabric, announced that chairman & CEO Jianquan Li proposed to acquire all outstanding shares of the company’s common stock which he and his wife don’t currently own at a rate of $4.30 in cash for each share.
WWIN shares jumped 17% to $3.98 as of about 12:10 p.m. today. Li and his wife beneficially own about 73.95% of the company’s stock already. Read more
NeuroMetrix lands $150,000 purchase order from Wal-Mart Canada
NeuroMetrix (NSDQ:NURO) accepted a purchase order from Wal-Mart Canada Corp. worth $150,000 for NC-stat DPNCheck devices and biosensors. Read more
Major Chinese hospital purchases Imris surgical theater
IMRIS Inc. (TSX:IM) announced that the First Affiliated Hospital of Zhengzhou University in Zhengzhou City, China, purchased a Visius surgical theater, featuring a high-field MR scanner that travels into the OR for imaging along ceiling-mounted rails. Read more
GPOs: Montel Aetnastak and Spacesaver Corp. sign deals with Premier
South Beach, Fla.-based Montel Aetnastak
and Fort Atkinson, Wisc.-based Spacesaver Corp. signed deals with Premier health care alliance for high density mobile storage systems, effective April 1. Read more
- Derma Sciences prices $20M offering
- Obalon Therapeutics raises $1.5M
- SpectraScience lands $433k in subcription deals
- Encision lands $1.5M in private placement
- Life Core Technologies lands half of hoped-for $2M Series A round
- Medical Action Industries lenders waive default covenants
- Medtronic (NYSE:MDT): Leerink Swann maintains "market perform" rating.
- St. Jude Medical (NYSE:STJ): Leerink Swann maintains "outperform" rating.
- Edwards Lifesciences (NYSE:EW): Leerink Swann maintains "outperform" rating.
- Optos plc (LON:OPTS): Jeffries maintains "buy" rating, ups target from £2.70 to £2.90.
- DexCom (NSDQ:DXCM): Leerink Swann initiates coverage at "market perform," and $12 price target.
- Volcano (NSDQ:VOLC): Leerink Swann maintains "outperform" rating.